Skip navigation
MOST POPULAR RELATED TAGS
  • TOPICS
  • SECTORS
  • COMPANIES
Pharmas Market Video Gallery
Discussing whether a new $487M investment from the government will help speed up the production of the most important va...
Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are...
PHARMA WATCH LIST
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

SPECIAL REPORT


Current DateTime: 05:01:40 28 Nov 2009
LinksList Documentid: 32984624

PHARMA'S MARKET VIDEO

» More

Current DateTime: 05:01:41 28 Nov 2009
LinksList Documentid: 31171988
Expiration DateTime: 11/28/2009 5:03:08 AM

RSS FEED

» Help

Current DateTime: 04:56:28 28 Nov 2009
LinksList Documentid: 31171995
powered by digg

Pharma's Market

Text Size
Jul.16
12:31 PM ET

Lilly
More than ten years after Pfizer [PFE  Loading...      ()   ] brought Viagra to market and brought erectile dysfunction out of the closet a new survey says a lot of men are still too embarrassed to talk about impotence with their doctor.

The study, paid for by Clialis-maker Eli Lilly [LLY  Loading...      ()   ], shows nearly 40 percent of men have never broached the subject with their physician, even though 82 percent of men know ED could be a symptom of serious health problems.

You can read all sorts of other fun factoid findings of the survey here. LLY claims it interviewed the 300 men who are at least 45 years old "to further understand men's current beliefs about ED and DE treatment options, as well as the perceptions men have about communicating with their healthcare professional about ED."

Yeah, uh-huh, sure.

I'm guessin' they knew I couldn't resist blogging about ED.

Lilly has turned Cialis--the pill that lasts in your system for a day-and-a-half--into a blockbuster. And it recently launched a one-a-day version of the drug. Pfizer sold nearly half-a-billion dollars worth of Viagra in the first quarter of this year. GlaxoSmithKline [GSK  Loading...      ()   ], Schering-Plough [SGP  Loading...      ()   ] and the German Bayer[BAY  Loading...      ()   ]  share Levitra which is an also-ran, me-too ED drug. But I do know one new Levitra convert. A certain co-worker, who will remain unnamed, recently told me he spent more than 300 bucks to fill a Levitra prescription his neighbor wrote for him. Mr. Anonymous said he'd grown frustrated with his primary care physician who would only write him tiny, apparently insufficient, prescriptions for Viagra.

I also wonder what, if any, impact General Motors' [GM  Loading...      ()   ]decision to cut healthcare benefits for retirees could have on ED drug sales. Especially if other companies follow GM's lead.

We'll get a read on more recent impotence pill sales when big pharma starts reporting earnings next week.

Questions?  Comments? 

© 2009 CNBC, Inc. All Rights Reserved

Tools:
PrintEmailAdd This share icon
Next Post
  • digg share
ADD COMMENTS
Remaining characters


Current DateTime: 01:06:31 28 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 01:03:47 28 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 01:03:47 28 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 01:06:07 28 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters